|
|
Blood, 1 January 2005, Vol. 105, No. 1, pp. 341-349.
Prepublished online as a Blood First Edition Paper on August 31, 2004; DOI 10.1182/blood-2004-03-1074.
 Previous Article | Table of Contents | Next Article 
NEOPLASIA
Retinoids and myelomonocytic growth factors cooperatively activate RARA and induce human myeloid leukemia cell differentiation via MAP kinase pathways
Annegret Glasow,
Natalia Prodromou,
Ke Xu,
Marieke von Lindern, and
Arthur Zelent
From the section of Hematological Oncology, Institute of Cancer Research, London, United Kingdom; and the Department of Hematology, Erasmus Medical Center (MC), Rotterdam, The Netherlands.
Use of all-trans-retinoic acid (ATRA) in combinatorial differentiation therapy of acute promyelocytic leukemia (APL) results in exceptional cure rates. However, potent cell differentiation effects of ATRA are so far largely restricted to this disease and long-term survival rates in non-APL acute myelogeneous leukemia (AML) remain unacceptably poor, requiring development of novel therapeutic strategies. We demonstrate here that myelomonocytic growth factors (granulocyte colony-stimulating factor [G-CSF] and/or granulocyte macrophage colony-stimulating factor [GM-CSF]) potentiate differentiation effects of ATRA in different AML cell lines and primary cells from patients with myeloid leukemia. The ligand-dependent activities of endogenous and transiently expressed retinoic acid receptor alpha (RAR ) isoforms can be potentiated by G/GM-CSF in U-937 cells and correlate with increased expression of ATRA-inducible RAR2 isoform. Specific inhibitors of mitogen mitogen-activated protein kinase (MAPK) (MEK)-1/-2 or p38 extracellular signal-related kinase (ERK) kinase diminish the ATRA as well as ATRA and G/GM-CSF-induced activation of the RAR proteins and decreased the differentiation-induced decline in cell numbers. Our data demonstrate that acting, at least in part, via the MAP kinase pathways, myelomonocytic growth factors enhance ATRA-dependent activation of the RAR isoforms and maturation of myeloid leukemia cells. These results suggest that combinatorial use of these agents may be effective in differentiation therapy of AML. (Blood. 2005;105:341-349)
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
J. Zhang, L.-P. Song, Y. Huang, Q. Zhao, K.-W. Zhao, and G.-Q. Chen
Accumulation of hypoxia-inducible factor-1{alpha} protein and its role in the differentiation of myeloid leukemic cells induced by all-trans retinoic acid
Haematologica,
October 1, 2008;
93(10):
1480 - 1487.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Glasow, A. Barrett, K. Petrie, R. Gupta, M. Boix-Chornet, D.-C. Zhou, D. Grimwade, R. Gallagher, M. von Lindern, S. Waxman, et al.
DNA methylation-independent loss of RARA gene expression in acute myeloid leukemia
Blood,
February 15, 2008;
111(4):
2374 - 2377.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Cunha De Santis, M. de Barros Tamarozzi, R. B. Sousa, S. E. Moreno, D. Secco, A. B. Garcia, A. S. G. Lima, L. H. Faccioli, R. P. Falcao, F. Q. Cunha, et al.
Adhesion molecules and differentiation syndrome: phenotypic and functional analysis of the effect of ATRA, As2O3, phenylbutyrate, and G-CSF in acute promyelocytic leukemia
Haematologica,
December 1, 2007;
92(12):
1615 - 1622.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Milella, M. Konopleva, C. M. Precupanu, Y. Tabe, M. R. Ricciardi, C. Gregorj, S. J. Collins, B. Z. Carter, C. D'Angelo, M. T. Petrucci, et al.
MEK blockade converts AML differentiating response to retinoids into extensive apoptosis
Blood,
March 1, 2007;
109(5):
2121 - 2129.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Cimino, F. Lo-Coco, S. Fenu, L. Travaglini, E. Finolezzi, M. Mancini, M. Nanni, A. Careddu, F. Fazi, F. Padula, et al.
Sequential Valproic Acid/All-trans Retinoic Acid Treatment Reprograms Differentiation in Refractory and High-Risk Acute Myeloid Leukemia.
Cancer Res.,
September 1, 2006;
66(17):
8903 - 8911.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Xu, F. Guidez, A. Glasow, D. Chung, K. Petrie, K. Stegmaier, K.-K. Wang, J. Zhang, Y. Jing, A. Zelent, et al.
Benzodithiophenes Potentiate Differentiation of Acute Promyelocytic Leukemia Cells by Lowering the Threshold for Ligand-Mediated Corepressor/Coactivator Exchange with Retinoic Acid Receptor {alpha} and Enhancing Changes in all-trans-Retinoic Acid-Regulated Gene Expression
Cancer Res.,
September 1, 2005;
65(17):
7856 - 7865.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
